Carla Coffin MD, MSc, FRCPC, FAASLD

Dr. Carla S. Coffin is a clinician scientist (Full Professor with tenure 2021, Hepatology). She completed her MSc using the woodchuck model of hepatitis B virus infection and her MD degree at Memorial University of Newfoundland and Labrador. Dr. Coffin is an internationally recognized expert on hepatitis B and hepatitis Delta. She has served on expert review panels for the World Health Organization Essential Medicines Committee (viral hepatitis), the International Coalition to Eliminate HBV Stakeholders group, the US Centers for Disease Control, and Chaired the Education subcommittee, Hepatitis B Special Interest Group, American Association for the Study of Liver Diseases. She has an integrated basic science-translational research program that is supported by the Canadian Institutes of Health Research (CIHR) as well as internationally competitive requests for proposals (RFPs) from the industry.

Dr. Coffin has participated in ~30 international hepatitis B virus (HBV) Phase I-IV clinical trials (including a member of the Trial Guidance and Publication committee). She was integral in establishing the Canadian Hepatitis B Research Network, which has enabled unique and well-characterized longitudinal national cohort studies and bio-repositories for HBV and hepatitis Delta virus. She is leading a multidisciplinary team at the University of Calgary using the woodchuck hepatitis virus model of hepatitis B to investigate HBV pathogenesis and test new anti-HBV therapies.